DELRAY BEACH, Fla., April 11, 2011 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or the "Company") (Nasdaq:PSID), a leader in next generation patient monitoring and diagnostics, announced today that its Easy Check™ Breath Glucose Detection Device has delivered positive results in preliminary laboratory testing that are within acceptable industry standards as set by the National Committee of Clinical Laboratory Standards (currently Clinical and Laboratory Standards Institute - NCCL) and the International Organization for Standardization (ISO). The Company has conducted initial side-by-side studies of its Easy Check™ device with the traditional strip and glucometer method, which requires a drop of blood, that have yielded consistent readings. The goal of the Company's Easy Check device is to eliminate a patient's need to prick his or her finger multiple times per day in order to get a blood sugar reading.
